Can the cardioprotective effect of microRNA-103 inhibitors be extended to women with polycystic ovary syndrome?

被引:0
|
作者
Ramaswamy, P. [1 ]
Sibin, M. K. [2 ]
Misra, P. [2 ]
Sahu, R. [3 ]
机构
[1] Armed Forces Med Coll, Multidisciplinary Res Unit, Pune, Maharashtra, India
[2] Armed Forces Med Coll, Dept Biochem, Pune, Maharashtra, India
[3] Armed Forces Med Coll, Dept Community Med, Pune, Maharashtra, India
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:1070 / 1072
页数:3
相关论文
共 50 条
  • [31] Exploring microRNA expression profile in follicular fluid to classify women with polycystic ovary syndrome
    Sorensen, A. E.
    Wissing, M. L.
    Englund, A. L. M.
    Dalgaard, L. T.
    HUMAN REPRODUCTION, 2015, 30 : 411 - 411
  • [32] Polycystic Ovary Syndrome Epigenetic Mechanisms and Aberrant MicroRNA
    Ilie, Ioana R.
    Georgescu, Carmen E.
    ADVANCES IN CLINICAL CHEMISTRY, VOL 71, 2015, 71 : 25 - 45
  • [33] Polycystic ovary morphology is associated with insulin resistance in women with polycystic ovary syndrome
    Hong, So-hyeon
    Sung, Yeon-Ah
    Hong, Young Sun
    Jeong, Kyungah
    Chung, Hyewon
    Lee, Hyejin
    CLINICAL ENDOCRINOLOGY, 2017, 87 (04) : 375 - 380
  • [34] Screening women with polycystic ovary syndrome for metabolic syndrome
    Dokras, A
    Bochner, M
    Hollinrake, E
    Markham, S
    VanVoorhis, B
    Jagasia, DH
    OBSTETRICS AND GYNECOLOGY, 2005, 106 (01): : 131 - 137
  • [35] Prevalence of metabolic syndrome in women with polycystic ovary syndrome
    Panidis, Dimitrios
    Macut, Djuro
    Tziomalos, Konstantinos
    Papadakis, Efstathios
    Mikhailidis, Konstantinos
    Kandaraki, Eleni A.
    Tsourdi, Elena A.
    Tantanasis, Theoharis
    Mavromatidis, George
    Katsikis, Ilias
    CLINICAL ENDOCRINOLOGY, 2013, 78 (04) : 586 - 592
  • [36] METABOLIC SYNDROME IN POLYCYSTIC OVARY SYNDROME TUNISIAN WOMEN
    Smaoui, Fatma
    Chaabouni, Khansa
    Elleuch, Aida
    Boudaya, Mariem
    Mezghani, Chema
    Chaabene, Kais
    Frikha, Madiha
    Ayadi, Fatma
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL 1) : E271 - E271
  • [37] Stress in women - Metabolic syndrome and polycystic ovary syndrome
    Diamanti-Kandarakis, Evanthia
    Economou, Frangiskos
    STRESS, OBESITY, AND METABOLIC SYNDROME, 2006, 1083 : 54 - 62
  • [38] Prevalence of metabolic syndrome in women with polycystic ovary syndrome
    Popovic, B.
    Macut, D.
    Bozic, I.
    Petakov, M.
    Ognjanovic, S.
    Isailovic, T.
    Damjanovic, S.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 426 - 427
  • [39] Prevalence of the metabolic syndrome in women with polycystic ovary syndrome
    Bregieiro Fernandes Costa, Laura Olinda
    Ribeiro Viana, Aline de Oliveira
    de Oliveira, Monica
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2007, 29 (01): : 10 - 17
  • [40] Prediction of metabolic syndrome in women with polycystic ovary syndrome
    Ersan, Firat
    Arslan, Esra
    Esmer, Aytul Corbaciglu
    Aydin, Serdar
    Gedikbasr, Asuman
    Gedikbasi, Ali
    Alkis, Ismat
    Ark, Cemal
    JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION, 2012, 13 (03) : 178 - 183